4D Medicine raises £3.4 million for unique biomaterial platform
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment. ...
Gregory Coleman is a Scienmag editorial specialist profile for Synthetic Biology coverage.
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment. ...
Long before photosynthesis brought free oxygen into the world, the earth was already populated by numerous organisms. Oxygen was life-threatening...
The field of synthetic biology, the science of manipulating biology, has a lot of “cooks in the kitchen,” which has...
Oak Brook, IL – Volume 29, Issue 2 of SLAS Technology, includes three original research articles covering skin cutaneous melanoma,...
The rapid adoption of AI and big data technologies in the biotechnology sector presents unique data privacy and security challenges....
Michelle Chen, Ph.D., Chief Business Officer of clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine (“Insilico”) was named...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine